ANTITUMOR-ACTIVITY; CROSS-TALK; GROWTH-FACTOR; PHASE-III; IN-VIVO; RAS; ANGIOGENESIS; MAPK; GEMCITABINE; TRIAL
CANCER LETTERS, v.331, no.2, pp.250 - 261
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.